Abstract
In this paper, I discussed the issue of R&D policy in medicine, with special references to clinical research. First of all, emphasis was placed on how this issue overlaps the issue of the Japanese economy as a whole. Next I surveyed the role of private resources of the R&D in general industries and how it can be contrasted with that of medicine. Finally, I discussed the future of R&D in medicine will depend on several different views on health care in Japan.